[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337240-105":59,"doc-detail-337240-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-landscape-of-immunogenic-cell-death-related-genes-predicts-the-overall-survival-and-immune-infiltration-status-of-non-small-cell-lung-carcinoma","The landscape of immunogenic cell death-related genes predicts the overall survival and immune infiltration status of non-small-cell lung carcinoma","","Non-small-cell lung cancer (NSCLC) represents the majority of lung cancer cases and shows limited responsiveness to many treatments, creating a need for robust biomarkers. Immunogenic cell death (ICD), a regulated form of cell death that activates adaptive immunity and long-term immune memory, is explored for its potential to improve NSCLC immunotherapy outcomes. Gene expression and clinical data were retrieved from GEO and TCGA, followed by enrichment and variant analyses, Cox and LASSO modeling, and external validation, producing an ICD-related 17-gene prognostic risk signature with a supporting nomogram and immune infiltration comparisons.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-landscape-of-immunogenic-cell-death-related-genes-predicts-the-overall-survival-and-immune-infiltration-status-of-non-small-cell-lung-carcinoma/337240/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-landscape-of-immunogenic-cell-death-related-genes-predicts-the-overall-survival-and-immune-infiltration-status-of-non-small-cell-lung-carcinoma/337240.png","ImageObject",300,407,{"name":92,"@type":93},"Aurelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of this study on NSCLC?","Question",{"text":112,"@type":113},"To develop and validate an ICD-related gene landscape that predicts overall survival and characterizes immune infiltration status in NSCLC patients.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the prognostic genes identified and the risk model built?",{"text":117,"@type":113},"Clinical information and gene expression profiles were collected from GEO and TCGA, then functional enrichment, variant analysis, and immune correlation analyses were performed. Univariate and multivariate Cox regression followed by LASSO regression generated a TCGA-based prognostic risk model containing 17 gene labels.",{"name":119,"@type":110,"acceptedAnswer":120},"How did patients differ between the low-risk and high-risk groups?",{"text":121,"@type":113},"The low-risk group showed a better prognosis with a significant survival difference, while the high-risk subgroup was more associated with immune-related signaling pathways. Immune infiltration levels were generally higher in the high-risk group, which also showed greater susceptibility to immune-checkpoint blockade (ICB) treatment.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337240,1790887371,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","Heliyon 11 (2025) e40869  \nContents lists available at ScienceDirect  \nHeliyon  \njournal [homepage:](homepage: www.cell.com/heliyon)[ www.cell.com/heliyon](homepage: www.cell.com/heliyon)  \nResearch article  \nThe landscape of immunogenic cell death-related genes predicts the overall survival and immune infiltration status of  \nnon-small-cell lung carcinoma  \nJian Zhang a,1, Huiying Lib,1, Xi Zhang b, Yue Yang c,**, Yue Sund,*  \na Department of Thoracic Surgery, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin, 150040, Heilongjiang, China b Department of Pathology, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin, 150040, Heilongjiang, China c Institute of cancer prevention and treatment, Harbin Medical University, 6 Baojian Road, Harbin, 150000, Heilongjiang, China  \nd Science and Technology Academic Department of Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin, 150040, Heilongjiang, China  \nA R T I C L E I N F O  \nKeywords:  \nNSCLC  \nImmunogenic cell death(ICD) Risk model  \nPrognosis  \nImmune infiltration  \nA B S T R A C T  \nBackground: Non-small cell lung cancer (NSCLC), which accounts for about 85 % of all lung cancers, currently exhibits insensitivity to most treatment regimens. Therefore, the identification of new and effective biomarkers for NSCLC is crucial for the development of treatment strategies. Immunogenic cell death (ICD), a form of regulated cell death capable of activating adaptive immune responses and generating long-term immune memory, holds promise for enhancing antitumor immunity and offering promising prospects for immunotherapy strategies in NSCLC. Methods: Clinical information and expressive profiles of NSCLC genes were retrieved from the GEO and TCGA databases. By combining these databases, the researchers were able to identify the appropriate genes for use in forecasting outcomes of patients with this type of cancer. We further performed functional enrichment, gene variants and immune privilege correlation analysis to determine the underlying mechanisms. This was followed by univariate and multivariate Cox regression and LASSO regression analyses, we developed a prognostic risk model based on the TCGA cohort, which included 17 gene labels. The results of the external validation were then used to identify the appropriate genes for use in predicting the survival outcome of patients with this type of cancer. In addition, a nomogram was created to help visualise the clinical presentation of the patients. For the analyses, we performed 50 functional and immunoinfiltration assessments for two risk groups.  \nResults: Using 17 genes (AIRE, APOH, CDKN2A, CEACAM4, COL4A3, CPA, DBH, F10, FCGRB, FGFR4, MMP1, PGLYRP1, SCGB2A2, SLC9A3, UGT2B17 and VIP), The researchers then created agene signature that could be used to identify patients with an increased risk of contracting cancer. They divided the patients into two groups based on their risk score. The low-risk group exhibited a better prognosis (P \u003C 0.01). The survival curve demonstrated that ICD-related models could accurately predict patient prognosis. Conversely, high-risk subgroups were closely associated with immune-related signaling pathways. The analysis of immune infiltration also showed that  \n* Corresponding author.  \n** Corresponding author.  \nE-mail addresses: [Jian_cheung@hrbmu.edu.cn](Jian_cheung@hrbmu.edu.cn) (J. Zhang), [lihuiying0606@163.com](lihuiying0606@163.com) (H. Li), [zxkorea@126.com](zxkorea@126.com) (X. Zhang), yangyue1010@sohu.  \ncom (Y. Yang), [moonsun95318@qq.com](moonsun95318@qq.com) (Y. Sun).  \n1 Contributed equally to this work.  \n[https://doi.org/10.1016/j.heliyon.2024.e40869](https://doi.org/10.1016/j.heliyon.2024.e40869)  \nReceived 24 August 2023; Received in revised form 27 November 2024; Accepted 1 December 2024 Available online 11 December 2024  \n2405-8440/© 2024 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC license ([http://cre","cbCaidPnWMJyKNMS","https://ap.wps.com/l/cbCaidPnWMJyKNMS","pdf",7870784,16,"English","# Background\n# Methods\n## Data sources and gene selection\n## Statistical modeling and validation\n## Functional enrichment and immune infiltration assessment\n# Results\n## 17-gene risk signature and prognostic stratification\n## Association with immune pathways and immune checkpoint blockade\n# Conclusion\n# Introduction","[{\"question\":\"What is the main goal of this study on NSCLC?\",\"answer\":\"To develop and validate an ICD-related gene landscape that predicts overall survival and characterizes immune infiltration status in NSCLC patients.\"},{\"question\":\"How were the prognostic genes identified and the risk model built?\",\"answer\":\"Clinical information and gene expression profiles were collected from GEO and TCGA, then functional enrichment, variant analysis, and immune correlation analyses were performed. Univariate and multivariate Cox regression followed by LASSO regression generated a TCGA-based prognostic risk model containing 17 gene labels.\"},{\"question\":\"How did patients differ between the low-risk and high-risk groups?\",\"answer\":\"The low-risk group showed a better prognosis with a significant survival difference, while the high-risk subgroup was more associated with immune-related signaling pathways. Immune infiltration levels were generally higher in the high-risk group, which also showed greater susceptibility to immune-checkpoint blockade (ICB) treatment.\"}]","The landscape of immunogenic cell death-related genes predicts the overall survival and immune infiltration status of non-small-cell lung carcinoma | PDF",1790018269,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d2054706e27837e1b55057c9cb8e05f.webp",983,1341,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ccda9e7c0c2c04dc2d8950847b6bfdd8.webp",982,1340,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2ec6c1eb243728cc1fdebcee983738f4.webp",981,1338,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7473055726a0cd7ffe58c7d5cb5ef91f.webp",980,1337]